Granite Bio
Developer of novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
2
Funding Rounds
$100.0m
Money raised
Overview
Developer of novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Lo***** |
|
- |
Funding series
Funding Series Analysis
The company Granite Bio has raised a total of $100m in funding over 2 rounds.
Key Insights:
- Granite Bio Series B Round, April 2025: $70m
- Granite Bio Series A Round, April 2025: $30m
Granite Bio Series B Round, April 2025
$70m
Granite Bio Series A Round, April 2025
$30m